BioCentury
ARTICLE | Clinical News

Ribavirin Biopartners 200 mg tablets regulatory update

April 19, 2010 7:00 AM UTC

The EC approved an MAA from Bioton's Biopartners GmbH unit for Ribavirin Biopartners 200 mg tablets to treat chronic hepatitis C virus (HCV) infection in combination with peginterferon alfa-2b or inte...